Armata Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARMP research report →
About the company
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics.
- CEO
- Deborah L. Birx
- IPO
- 1994
- Employees
- 60
- HQ
- Marina del Rey, CA, US
Price Chart
- Market Cap
- $216.23M
- P/E
- -0.76
- P/S
- 73.10
- P/B
- -0.69
- EV/EBITDA
- -2.23
- Div Yield
- 0.00%
- Gross Margin
- 72.18%
- Op Margin
- -1258.55%
- Net Margin
- -9554.23%
- ROE
- 162.59%
- ROIC
- -57.13%
- Revenue
- $4.90M · -5.22%
- Net Income
- $-173,799,000 · -818.79%
- EPS
- $-4.80 · -823.08%
- Op Income
- $-31,222,000
- FCF YoY
- 33.29%
- 52W High
- $16.34
- 52W Low
- $1.93
- 50D MA
- $8.31
- 200D MA
- $7.39
- Beta
- 1.23
- Avg Volume
- 109.42K
Get TickerSpark's AI analysis on ARMP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 24, 26 | Gilmer Daniel B. | other | 51,280 |
| Apr 24, 26 | Gilmer Daniel B. | other | 0 |
| Mar 14, 26 | Kyme Pierre | other | 1,030 |
| Mar 14, 26 | Birx Deborah | other | 4,919 |
| Mar 9, 26 | Kramer Robin | other | 25,640 |
| Mar 9, 26 | Kyme Pierre | other | 183,142 |
| Mar 9, 26 | House David Duane | other | 109,885 |
| Mar 9, 26 | PATTI JOSEPH M | other | 25,640 |
| Mar 9, 26 | Peterson Todd C. | other | 25,640 |
| Mar 9, 26 | Odysseas Kostas D | other | 25,640 |
Our ARMP coverage
Recent articles, reports, and earnings notes.
No research on ARMP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ARMP report →Similar companies
Peers in the same neighborhood.